Cable Hill Partners’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,500
Closed -$26K 237
2019
Q1
$26K Hold
3,500
0.01% 332
2018
Q4
$28K Buy
3,500
+1,500
+75% +$14.9K 0.01% 308
2018
Q3
$24K Buy
2,000
+1,000
+100% +$12.5K 0.01% 282
2018
Q2
$11K Hold
1,000
﹤0.01% 449
2018
Q1
$7K Hold
1,000
﹤0.01% 570
2017
Q4
$7K Hold
1,000
﹤0.01% 649
2017
Q3
$6K Hold
1,000
﹤0.01% 707
2017
Q2
$4K Buy
+1,000
New +$4.38K ﹤0.01% 591

Other funds holding CTSO

Cable Hill Partners's CTSO Position: Q2 2019 in Review

Cable Hill Partners sold out of Cytosorbents Corp (CTSO) in Q2 2019, closing a stake of 3,500 shares — an estimated $26K sold.

Cable Hill Partners first reported a position in CTSO in Q2 2017 and held it in 8 quarters. The position peaked at $28K in Q4 2018. 72 funds tracked by Wall St. Rank hold CTSO as of Q2 2019.

  • Cable Hill Partners reported no remaining Cytosorbents Corp position as of Q2 2019 after selling out during the quarter.
  • Cable Hill Partners sold 3,500 Cytosorbents Corp shares in Q2 2019, an estimated $26K.
  • Cable Hill Partners first reported a position in Cytosorbents Corp in Q2 2017 and held it in 8 quarters.
  • Cable Hill Partners's Cytosorbents Corp position peaked at $28K in Q4 2018.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2019.

Based on Cable Hill Partners's 13F filing for Q2 2019, filed 6 Aug 2019.